0001562180-21-000646.txt : 20210129
0001562180-21-000646.hdr.sgml : 20210129
20210129200236
ACCESSION NUMBER: 0001562180-21-000646
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210129
FILED AS OF DATE: 20210129
DATE AS OF CHANGE: 20210129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kennedy Joseph T
CENTRAL INDEX KEY: 0001408920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21392
FILM NUMBER: 21573743
MAIL ADDRESS:
STREET 1: C/O TRANSCEPT PHARMACEUTICALS, INC.
STREET 2: 1003 W. CUTTING BLVD., SUITE 110
CITY: POINT RICHMOND
STATE: CA
ZIP: 94804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMARIN CORP PLC\UK
CENTRAL INDEX KEY: 0000897448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
BUSINESS PHONE: 353 1 6699 020
MAIL ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
FORMER COMPANY:
FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC
DATE OF NAME CHANGE: 20000201
FORMER COMPANY:
FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC
DATE OF NAME CHANGE: 19930322
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-01-29
false
0000897448
AMARIN CORP PLC\UK
AMRN
0001408920
Kennedy Joseph T
C/O AMARIN PHARMA, INC.
440 US HIGHWAY 22
BRIDGEWATER
NJ
08807
false
true
false
false
General Counsel
Ordinary Shares
2021-01-29
4
M
false
26000.00
A
240399.00
D
Ordinary Shares
2021-01-29
4
M
false
12733.00
A
253132.00
D
Ordinary Shares
2021-01-29
4
F
false
15351.00
7.50
D
237781.00
D
Ordinary Shares
2021-01-29
4
M
false
1806.00
A
239587.00
D
Ordinary Shares
2021-01-29
4
M
false
1806.00
A
241393.00
D
Ordinary Shares
2021-01-29
4
F
false
1360.00
7.50
D
240033.00
D
Restricted Stock Units
0.00
2021-01-29
4
M
false
26000.00
0.00
D
Ordinary Shares
26000.00
0.00
D
Restricted Stock Units
0.00
2021-01-29
4
M
false
12733.00
0.00
D
Ordinary Shares
12733.00
12733.00
D
Restricted Stock Units
0.00
2021-01-29
4
M
false
1806.00
0.00
D
Ordinary Shares
1806.00
12636.00
D
Restricted Stock Units
0.00
2021-01-29
4
M
false
1806.00
0.00
D
Ordinary Shares
1806.00
12636.00
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
On February 1, 2018, the Reporting Person was granted 78,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021.
Not applicable.
On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021.
Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 260,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.
Please see the section titled "Remarks" below for additional information.
Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 1,327,736 Ordinary Shares of the Issuer in the form of Ordinary Shares, stock options and RSUs outstanding under the Issuer's stock incentive plans, including but not limited to certain performance-based RSUs that are earned only if certain pre-defined operational milestones are achieved and, in certain cases, then vest only if the recipient remains with the company for an extended period of time.
/s/ Joseph T. Kennedy
2021-01-29